Organogenesis Holdings Inc. ORGO Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organogenesis Holdings Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Organogenesis Holdings Inc.'s accounts receivable?
- Organogenesis Holdings Inc. (ORGO) reported accounts receivable of $116.91M in Q1 2026.
- How has Organogenesis Holdings Inc.'s accounts receivable changed year-over-year?
- Organogenesis Holdings Inc.'s accounts receivable increased by 13.2% year-over-year, from $103.32M to $116.91M.
- What is the long-term trend for Organogenesis Holdings Inc.'s accounts receivable?
- Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s accounts receivable has grown at a 30.8% compound annual growth rate (CAGR), from $56.8M to $217.45M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.